Although the results reported in this communication are consistent with our previous work [16] that found that SIRT1-null mice were not differentially sensitive to oncogenic treatments, these results are at odds with other reports [8,9] that suggest that SIRT1 has tumor suppressive properties. The gene discussed is SIRT1; the disease is neoplasm.